文献速递头颈部肿瘤放疗

局部晚期口腔鳞癌第二原发恶性肿瘤的表现与结局:III期随机对照试验二次分析

Presentation and outcomes of second primary malignancies (SPMs) in locally advanced oral cavity squamous carcinoma (LA-OSCC): Secondary analysis of a phase III randomised control trial (NCT00193843).
PubMed 文献 · Radiother Oncol · 2025-05-21

SPM诊断后2年总生存率30.3%,无进展生存率21.6%;SPM发生时间超过2年及对SPM进行手术治疗与更优的无进展生存相关。

要点

  • 口腔鳞癌幸存者中SPM的5年累积发病率为11%,中位发生时间48个月。
  • SPM诊断后2年总生存率30.3%,无进展生存率21.6%。
  • SPM发生时间超过2年及对SPM进行手术治疗与更优的无进展生存相关。

核心结论

  • SPM可导致口腔鳞癌幸存者显著发病和死亡,需制定早期检测和积极挽救策略。

主要发现

  • 存活患者中位随访95.9个月(IQR 76.1-122.4个月),共检测到83例SPM,中位发生时间48个月(IQR 20-87个月),5年累积发病率11%。
  • 头颈部是最常见的SPM发生部位。
  • SPM诊断后2年Kaplan-Meier估计的总生存率为30.3%(95%CI 20.9%-43.9%),无进展生存率为21.6%(95%CI 13.8%-34%)。
  • 多因素分析显示,SPM发生时间超过2年及对SPM进行手术治疗与更优的无进展生存相关。

临床怎么用

  • 对口腔鳞癌幸存者应关注SPM的早期检测,尤其是头颈部部位。
  • 对发生的SPM应考虑积极的手术挽救治疗,以改善无进展生存。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Second Primary Malignancies (SPMs) are a common cause of morbidity and mortality in Head & Neck Squamous Carcinoma (HNSCC). Prospective data on incidence, outcomes and prognostic factors is sparse. The current publication summarizes data on 83 SPMs which developed on follow up among patients accrued on a Phase III Randomized Controlled Trial testing treatment intensification in Oral Cavity Squamous Carcinoma (OSCC). PATIENTS AND METHODS: Nine hundred patients of OSCC accrued between 2005-2013 were followed up as part of the trial protocol. Standard clinical criteria were used to determine SPM occurrence. Clinicopathological and demographic variables were summarized using descriptive statistics and analysed using measures of central tendency and dispersion. Outcomes of interest included Overall-Survival (OS) and Progression-Free-Survival (PFS) post SPM diagnosis and were analysed using the Kaplan-Meier method and factors of prognostic significance were compared using the log-rank test and multivariate analysis thereafter. RESULTS: The median follow-up of surviving patients was 95.9 months {(IQR) = 76.1-122.4 months}. A total of 83 SPMs were detected at a median time-to-occurrence of 48 months (IQR-20-87 months) (Cumulative Incidence -11 % at 5 years). The Head & Neck was the most common site of SPM. The 2-year Kaplan Meier estimates of OS and PFS post diagnosis of SPM were 30.3 % (95 %CI-20.9 %-43.9 %) and 21.6 % (95 %CI-13.8 %-34 %) respectively. Multivariate analysis revealed time-to-development of SPM more than 2 years and surgical management of SPM to be associated with superior PFS. CONCLUSIONS: SPMs can cause major morbidity and mortality in OSCC survivors. Strategies need to be developed to gear towards early detection and aggressive salvage.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Laskar SG, Sood S, Chatterjee A, et al. Presentation and outcomes of second primary malignancies (SPMs) in locally advanced oral cavity squamous carcinoma (LA-OSCC): Secondary analysis of a phase III randomised control trial (NCT00193843). Radiother Oncol. 2025. PMID: 40409369. doi:10.1016/j.radonc.2025.110944

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。